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Abstract. Oxidative stress has been proposed as a com- 
mon mediator of apoptotic death. To investigate fur- 
ther the role of oxidants in this process we have studied 
the effects of antioxidants on Sindbis virus (SV)- 
induced apoptosis in two cell lines, AT-3 (a prostate 
carcinoma line) and N18 (a neuroblastoma line). The 
thiol antioxidant, N-acetylcysteine (NAC), at concen- 
trations above 30 mM, completely abrogates SV- 
induced apoptosis in AT-3 and N18 cells. The effects of 
NAC cannot be attributed to inhibition of viral entry or 
viral replication, changes in extracellular osmolarity or 
to increases in cellular glutathione levels, nor can they 
be mimicked by chelators of trace metals, inhibitors of 
lipid peroxidation or peroxide scavengers. In contrast, 
other thiol agents including pyrrolidine dithiocarbam- 
ate (PDTC, 75 IxM) are protective. Because NAC and 
PDTC are among the most effective inhibitors of the 
transcription factor NF-kappa B, we examined SV's 
ability to activate NF-kappa B before the onset of mor- 
phologic or biochemical evidence of apoptosis. Within 
hours of infection, SV induced a robust increase in nu- 
clear NF-kappa B activity in AT-3 and N18 cells; this 
activation was suppressible by NAC and PDTC. Over- 
expression of bcl-2 in AT-3 cells, which has been shown 
to inhibit SV-induced apoptosis, also inhibits SV- 
induced NF-kappa B activation. To determine if NF- 
kappa B activation is necessary for SV-induced apopto- 
sis in these cells, we used double stranded oligonucle- 
otides with consensus NF-kappa B sequences as tran- 
scription factor decoys (TFDs) to inhibit NF-kappa B 
binding to native DNA sites. Wild-type, but not mu- 
tant, TFDs inhibit SV-induced apoptosis in AT-3 cells. 
In contrast, TFD inhibition of NF-kappa B nuclear ac- 
tivity in N18 cells did not prevent SV-induced apopto- 
sis. Taken together, these observations define a cell 
type-specific, transcription factor signaling pathway 
necessary for SV-induced apoptosis. Understanding the 
precise mechanism by which Bcl-2 and thiol agents in- 
hibit SV-induced nuclear NF-kappa B activity in AT-3 
cells may provide insights into the pluripotent anti- 
apoptotic actions of these agents. 
I 
NFECTION of mice with Sindbis virus (SV) 1 results in 
encephalitis and has thus been used to model human 
encephalitides due to alphaviruses (Strauss and Strauss, 
1994). Encephalitis results primarily from infection of neu- 
rons of the central nervous system. Studies of SV infection 
in vitro in cell lines and primary cultured neurons reveal 
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two distinct outcomes of infection: (a) lytic infection in which 
intracellular replication of the virus leads to apoptotic cell 
death, or (b) persistent infection in which the virus pro- 
duces progeny without killing the host cell (Levine et al., 
1993). Under circumstances that lead to lytic infection, SV 
induces all the morphologic characteristics of apoptosis: 
chromatin condensation, DNA fragmentation and mem- 
brane blebbing (Levine et al.,  1993). These morphologic 
changes reflect the events that lead to compartmentaliza- 
tion of the cell. Fragments of apoptotic cells can then be 
phagocytized by macrophages or neighboring cells before 
there  is  leakage  of cytoplasmic contents  (Wyllie et  al., 
1980; Kerr and Harmon, 1991; Barr and Tomei, 1994). 
Neuronal outcome in the presence of SV infection ap- 
pears to be regulated by developmental factors. Persistent, 
non-lytic infection by alphaviruses has been observed in 
weanling and adult mice as well as adult humans (Griffin 
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virus is continuously produced by neurons, but viability of 
neurons and the organism is  maintained. Newborn mice 
infected with SV, on the other hand, experience lytic neu- 
ronal infection and death. Primary neurons cultured in vitro 
(in the absence of immune cells) display a similar develop- 
mental susceptibility to lytic SV infection. Thus, while the 
distinct  outcomes  of SV  infection  appear  to  depend  in 
part, on developmentally regulated virus-host interactions, 
the precise signals which govern lytic (apoptotic) infection 
versus persistent infection remain unclear. 
An important clue to the mechanism by which SV induces 
apoptosis comes from the observation that overexpression 
of the proto-oncogene bcl-2 (Cleary et al., 1986; Tsujimoto 
and  Croce,  1986)  in  cultured  cell  lines  prevents  SV- 
induced apoptosis  and  allows a  persistent  infection (Le- 
vine et al., 1993). In addition to preventing SV-induced ap- 
optosis, Bcl-2 can prevent cell death induced by growth 
factor deprivation, the calcium ionophore A23187, chemo- 
therapeutic agents,  oxidative stress  (Zhong  et  al.,  1993) 
and influenza virus (Hinshaw et al., 1994). Although Bcl-2 
is not protective in all apoptotic paradigms, its broad spec- 
trum of action suggests that the death program triggered 
by multiple stimuli converge at, or before, a  step that is 
blocked by Bcl-2. 
One attractive but controversial hypothesis of Bcl-2 ac- 
tion contends that oxidative stress induced by diverse apop- 
totic stimuli is  a critical step in triggering cell death and 
that Bcl-2 acts to neutralize the damaging effects of oxi- 
dants (Hockenbery et al., 1993) or to directly scavenge ox- 
idants (Kane et al., 1993).  This hypothesis has been chal- 
lenged by recent studies which demonstrate that apoptosis 
induced by certain stimuli proceeds in the absence of oxy- 
gen radicals and that Bcl-2 can protect under these hyp- 
oxic conditions (Jacobson and Raft, 1995; Shimizu et al., 
1995).  However, support for a role for oxidative stress as 
one type of mediator of apoptosis comes from observa- 
tions from several laboratories demonstrating that in cul- 
tured cells addition of oxidants or inhibition of antioxidant 
defenses leads to apoptosis (McConkey et al., 1988; Len- 
non  et  al.,  1991;  Hockenbery et  al.,  1993;  Ratan  et  al., 
1994a, b; Rothstein et al., 1994; Troy and Shelanski, 1994). 
Additionally, overexpression of antioxidant enzymes (Hock- 
enbery et al., 1993; Greenlund et al., 1995), or treatment of 
cells with antioxidants (Mayer and Noble, 1994a;  Ferrari 
et al., 1995) abrogates apoptosis induced either by growth 
factor deprivation, by endotoxin (Abello et al., 1994) or in 
thymocytes, by dexamethasone or etoposide (Wolfe et al., 
1994). Finally, serum deprivation-induced apoptosis in cul- 
tured neurons has been shown to be linked to an increase 
in radical production (Zhong et al., 1993; Greenlund et al., 
1995).  These findings have focused attention on defining 
whether apoptosis induced by divergent stimuli, including 
viruses, is triggered by an oxidative signal and, if so, identi- 
fying the molecular targets of that signal. 
In a previous study, we demonstrated that neuronal apop- 
tosis  can be induced by cystine deprivation, glutathione 
depletion and oxidative stress in cortical neuronal cultures 
(Ratan et al.,  1994a).  In this paradigm, protein synthesis 
inhibitors abrogate oxidatix,  e stress-induced apoptosis by 
shunting cysteine from global protein synthesis to the thiol 
antioxidant, glutathione rather than by inhibiting specific 
death  proteins  (Ratan  et  al.,  1994b).  N-acetylcysteine 
(NAC), an agent which increases glutathione levels in cor- 
tical neurons by 50%, also prevents cystine deprivation- 
induced apoptosis (Ratan et al., 1994b). We thus sought in 
the present study to determine whether SV-induced apop- 
tosis  is  associated  with  a  depletion  of glutathione  and 
whether NAC could inhibit SV-induced death. 
Herein, we demonstrate that NAC (30 mM) and other 
thiol agents, pyrrolidine dithiocarbamate  (PDTC), DTT, 
and 2-mercaptoethanol (2-ME) block SV-induced apopto- 
sis.  However, in this paradigm, NAC's protective effects 
do not depend on its ability to increase glutathione levels. 
Rather,  the  protective effects of NAC  (and  other  thiol 
agents) correlate with their ability to inhibit SV-induced 
activation of the transcription factor NF-kappa B. Further- 
more, we report that suppression of NF-kappa B  activa- 
tion, either by Bcl-2 or by synthetic, double stranded NF- 
kappa B oligonucleotides employed as transcription factor 
decoys, inhibits SV-induced death in AT-3 prostate carci- 
noma cells. These results define NF-kappa B activation as 
a necessary component of SV-induced apoptosis in AT-3 
cells and suggest that thiol agents such as NAC and anti- 
apoptotic proteins such as Bcl-2 may inhibit apoptosis, in 
part, by acting on an NF-kappa B signaling pathway. 
Materials and Methods 
Cell Culture and Viability Studies 
Mouse N18 neuroblastoma cells were grown as described (Levine et al., 
1993) in MEM media containing 10% fetal calf serum, 2 mM L-glutamine, 
penicillin (50 units/ml), and streptomycin (50 Ixg/ml). For viability studies, 
the cells were plated in 24-well dishes at a density of 80,000 cells/ml. One 
day after plating, the media was changed and fresh media containing the 
following drugs alone  or  in combination  (as designated in  the results) 
were added: N-acetylcysteine (0.1-80 mM), N-acetylserine (30-80 mM), 
buthionine sulfoximine (20  txM),  deferoxamine mesylate (10-500  I~M), 
mimosine (50-500 IxM), penicillamine (10 txM-1 mM), butylated hydroxy- 
anisole  (10-100  IxM),  trolox  (10  ~M-1  mM),  catalase  (purified  from 
erythyrocytes  or  Aspergillus  Niger;10-10,000  units/ml),  dithiothreitol 
(0.1-10  mM),  2-mercaptoethanol  (0.15-15  mM),  pyrrolidine  dithiocar- 
bamate (10-100  IJ.M), or diethyl dithiocarbamate (10 txM-10 mM). 2  h 
later, the media was changed to MEM containing low serum (2% fetal calf 
serum) and Sindbis virus (strain AR339) was added at multiplicity of in- 
fection of 1-5 plaque-forming units (PFU)/cell. After a  1-h infection pe- 
riod,  the low  serum media  was  replaced  with  normal media.  In  cases 
where the effects of pharmacologic agents were being evaluated, the drugs 
were maintained in the medium during and after infection. Viability was 
then assessed 48 h later using trypan blue exclusion (Levine et al., 1993) 
LDH release, ethidium homodimer (Ethid-1; Molecular Probes, Eugene, 
OR) staining or DNA fragmentation as previously described (Ratan et al., 
1994a, b). Parallel studies were performed using the same drug treatments 
with AT-3 cells stably expressing pZip containing a neomycin resistance 
gene (Levine et al., 1993).  AT-3 Neo cells were grown as previously de- 
scribed and plated in 24-well dishes at a density of 10,000 cells/well. 
Replication In Vitro 
N18 and AT-3 cells were grown to near confluency in 12-well  plates and 
infected as described above. Supernatant fluid was removed from 3 wells 
at 4, 24, and 48 h after infection, virus from each well was quantitated by 
plaque formation in BHK-21 cells (PFU/ml), and the geometric mean was 
determined for each time point. 
Glutathione Measurements 
Total glutathione levels (GSH +  GSSG) were measured using the method 
of Tietze (1969) as previously described (Ratan et al., 1994b). Briefly, at var- 
ious intervals after infection, control and infected ceils plated in 6-well dishes 
The Journal of Cell Biology, Volume 131, 1995  1150 were washed once with cold PBS. 1 ml of cold 3% perchloric acid was added 
per well and cells were scraped off the bottom of the dish using a rubber po- 
liceman.  The lysates were collected  in eppendorf tubes and spun at 4°C at 
7,400 g. The supernatants were diluted with nine volumes of 0.1 M Na2HPO4 
and the remaining steps of the glutathione  assay were performed as previ- 
ously described (Ratan et al., 1994b). Glutathione levels were normalized 
to total protein. Protein levels were determined using the bicinchoninic  acid 
reagent (Pierce Chem. Co., Rockford, IL) method (Smith et al., 1985). 
EMSA Assays and Supershift Analysis 
To investigate whether SV infection triggers NF-kappa B activation,  we 
performed electrophoretic mobility shift assays (EMSAs) on nuclear ex- 
tracts  from infected  and  uninfected  mouse N18  neuroblastoma, AT-3 
Neo, or AT-3 Bcl-2 cells  using a 32p-labeled  oligonucleotide with a con- 
sensus NF-kappa B binding site.  We chose the palindromic NF-kappa B 
sequence that lies upstream of the MHC Class I promoter (5'-GGG GAT 
TCC CC-3'). Parallel  EMSAs were performed in infected and uninfected 
cells  using  radiolabeled  AP-1  (5'-CGC  TTG  ATG  ACT  CAG  CCG 
GAA-3') consensus binding sites.  Briefly,  107 N18 cells or 4 x  106 AT-3 
cells were infected with SV as described. At various times after infection, 
cells were lightly trypsinized, pelleted, and resuspended in PBS. All subse- 
quent steps were performed at 4°C. The cells were incubated for 17 min in 
400 pJ of a hypoosmotic buffer (10 mM Hepes, pH 7.8, 10 mM KC1, 2 mM 
MgCl2, 0.1  mM EDTA,  10  izg/ml aprotinin, leupeptin 0.5  p,g/ml, 3 mM 
PMSF,  and 3 mM DTT). 25  txl of 10%  NP-40  was added and the nuclei 
were pelleted by centrifugation for 5 min in a microfuge. The supernatants 
containing the cytoplasmic proteins were removed and stored at -70°C; 
the pelleted nuclei  were resuspended in a high salt buffer (50 mM Hepes, 
pH 7.4, 50 mM KCI, 300 mM NaC1, 0.1  mM EDTA, 10%  (vol/vol)  glyc- 
erol, 3 mM DT£, and 3 mM PMSF) to solubilize  DNA binding proteins. 
The resuspended nuclei were gently shaken for 30 min at 4°C. The ex- 
tracts were spun in a microcentrifuge for 10 min and the clear superna- 
tants  containing nuclear  protein  were  aliquoted  and  stored  at  -70°C. 
PCA precipitated protein was measured from a representative aliquot of 
each sample and equal amounts were used for binding. Binding reactions 
were performed at room temperature for 15 min using 4-8 Ixg of nuclear 
protein (NF-kappa B or AP-1) and 0.25 ng (25,000 cpm) of labeled oligo- 
nucleotide in 30 ~tl of binding buffer containing 10 mM Tris-HCl, pH 7.5, 
50 mM NaC1, 50 mM KCI, 1 mM MgCl2, 1 mM EDTA, 5 mM DTT, 5% 
glycerol,  and 2  txg poly dIdC.  DNA-protein complexes were separated 
from unbound probe on native 4.5 % polyacrylamide gels at 200-250 V for 
2-3 h. The resultant gel was vacuum dried and exposed to Kodak film for 
8-15 h at -80°C. Visual inspection of the free probe band at the bottom of 
the  gel  confirmed that equivalent amounts of radiolabeled  probe were 
employed for each sample (data not shown). Cold competition was per- 
formed using consensus (5'-GGGGACTTTCCC-3') or mutant NF-kappa 
B  binding sites (5'-GGCGACTTTCCC-3')  (Santa Cruz Biotechnology, 
Santa  Cruz,  CA).  Supershifts were  performed with  antibodies  to  NF- 
kappa B subunits Rel A, pS0, c-rel, or rel-B  or antibodies to C-fos, C-jun, 
or Egr-1  (Santa Cruz Biotechnology). The antibody (1 or 2 Ixl) was added 
to the binding mixture immediately after the addition of the radiolabeled 
NF-kappa B probe. The reaction mixture was incubated for 20 min and 
the complexes resolved as described above. Specificity  of the antibodies 
for the corresponding subunit were confirmed by adding 200 ng of control 
peptide (Santa Cruz Biotechnology) prior to addition of the antibody to 
the reaction mixture. 
NF-kappa B Transcription Factor Decoy Experiments 
Phosphorothioated oligonucleotides were made as previously described 
(Higgins et al., 1993). The double stranded thioate competitors used as de- 
coys were prepared by annealing complementary strands in vitro in lx 
annealing buffer (20  txM  Tris-HC1,  pH 7.5; 20  #M  MgC12, and  50  IxM 
NaCl). The mixture was heated to 100°C for 12 min and allowed to cool to 
room temperature slowly  over 2 h. The kB-1  wild-type (WT) sequence 
was 5' CCA GGA GAT TCC ACCCAG  GAG ATT CCA CCC AGG 
AGA TTC CACC 3', and the mutant kB-1  sequence was 5'-GTC TGA 
GAT TCC ACG TCT GAG ATT CCA CGT CTG AGA TTC CACG 3'. 
The kB-2 WT sequence was 5' GGGG ACT TTC CGC TGG GGA CT[ 
TCC  AGG  GGG ACT TI'C C  3',  and the mutant kB-2  sequence was 
5'GTC TAC ITI  CCG CTG TCT ACT TTC CAC GGT CTA CTT TCC 
3'. A  previous study employed EMSAs and demonstrated that the WT 
phosphorothioated decoy oligonucleotides used in the present study are 
capable of binding NF-kappa B, but mutant decoy oligonucleotides are 
not (Sharma et al., 1995). 
For viability  studies N18 cells and AT-3 cells were grown as described 
in 24-well or 6-well tissue culture plates. Kappa B-1 or kappa B-2 TFDs 
(0.125-30  ~M) and the corresponding mutant TFDs were added directly 
to the bathing medium. After 18-24  h, the medium was changed, fresh 
TFD was added and the cells were infected with SV (AR339) as described 
above. 48 h later, the viability  was measured by the percentage of lactate 
dehydrogenase (LDH) released into the medium or ethidium homodimer 
staining as previously described.  DNA laddering was also assessed 18-24 h 
after infection as described (Ratan et al., 1994a, b). In parallel,  cells grown 
in 100-mm dishes (4 x  106 cells/dish)  were treated with individual  TFDs or 
their corresponding mutants for 18-24  h and then infected as described 
above. At various intervals up to 4 h after infection, cells were harvested 
for preparation of nuclear extracts as described  above.  Subsequently, 
EMSAs were performed to evaluate the effects of WT TFDs and mutant 
TFDs on NF-kappa B activation.  Nuclear extracts used for these EMSAs 
were also utilized  to examine the effects  of NF-kappa B TFDs on AP-1 
nuclear binding. 
Results 
NA  C Inhibits SV-Induced Apoptosis 
Infection of Mouse N18 neuroblastoma cells or rat AT-3 
prostate carcinoma cells with SV (strain AR339, multiplic- 
ity of infection 1-5) has been shown to result in chromatin 
condensation and DNA fragmentation typical of apoptosis 
within 14-24 h (Levine et al., 1993). Associated with these 
morphologic and biochemical changes, viability of infected 
cells, as monitored by trypan blue exclusion or LDH re- 
lease, decreases to 5-15% of uninfected controls after 48 h 
(Fig. 1 A). 
We have previously shown that 100  p~M NAC prevents 
oxidative stress-induced apoptosis in cortical neurons (Ra- 
tan et al., 1994b). To investigate whether SV (AR339) in- 
duces apoptosis through a similar pathway, we examined 
the effects of NAC on SV(AR339)-induced  death. While 
100  ~zM NAC was not protective, concentrations of NAC 
above 30 mM completely inhibit SV(AR339)-induced  ap- 
optosis  in  N18  neuroblastoma  cells  (Fig.  1 A)  or  AT-3 
prostate carcinoma cells (not shown). To determine whether 
NAC protection was due to inhibition of viral entry or vi- 
ral replication we measured the cumulative amount of vi- 
rus produced by AT-3 (Fig. 1 B) and N18 cells (not shown) 
in the presence and absence of NAC at 4, 24, or 48 h after 
infection. At each time point examined, viral titers were sim- 
ilar  in  control  and  NAC-treated  cells  infected  with  SV 
(AR339) (Fig. 1 B). 
To exclude the possibility that nonspecific effects related 
to the high concentrations of drug used were responsible 
for NAC protection, we treated cells with N-acetylserine 
(NAS) (Staal et al., 1993).  NAS differs from NAC in that 
it has a hydroxyl group rather than a sulfhydryl group and 
therefore cannot act to increase glutathione or directly scav- 
enge radicals (Fig. 1 C). As shown in Fig. 1 C, NAC com- 
pletely suppressed SV (AR339)-induced apoptosis, whereas 
the same concentration of NAS revealed only a small de- 
gree of protection. Thus, the inhibitory effects of NAC de- 
pend almost completely on its reducing thiol group and not 
from nonspecific changes such as osmolarity associated with 
the presence of a high concentration of reagent. 
NA  C Inhibition of SV-induced Apoptosis Does Not 
Depend on Glutathione Synthesis 
As mentioned previously, one of the proposed mechanisms 
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Figure 1.  NAC promotes survival of N18 cells infected with Sind- 
bis virus and this protection cannot be attributed to inhibition of 
viral entry or viral replication, changes in extracellular osmolarity 
or its ability to increase glutathione levels. (A) Concentration re- 
sponse  of NAC protection  48  h  after  SV-infection. Cells  were 
plated in 0.5 ml of MEM medium containing either no additive or 
the indicated concentrations  of NAC. Viability was  assessed  by 
trypan  blue exclusion and percent LDH release as described in 
the Materials and Methods.  Error bars represent  SEM (n  =  5). 
(B) Cumulative Sindbis Virus production is unaltered by 30 mM 
NAC in N18 cells (not shown) and AT-3 cells. At 4, 24, or 48 h af- 
ter infection,  the  media  of infected cells (+/-  NAC)  were  col- 
lected and viral titers were measured in plaque forming units per 
ml of media (PFU/ml) as described in the Materials and Methods. 
Error bars represent SEM (n  =  5).  (C) 50 mM NAC but not 50 
mM N-acetyl-L-serine (NAS) completely abrogates  SV-induced 
apoptosis in N18 cells suggesting that NAC protection is not de- 
pendent  on non-specific effects such  as changes in extracellular 
osmolarity. NAS differs from NAC in that it has a hydroxyl group 
rather than a sulfhydryl group and therefore cannot act to increase glutathione or directly scavenge radicals. Error bars represent SEM 
(n =  3). Asterisk denotesp <  0.05.  (D) 20 ~M BSO depletes total glutathione to less than 30% of control in the presence or absence of 
NAC. Total glutathione  (GSSG  +  GSH)  Ixg (normalized to total protein) was measured 3, 8,  11, and 13 h  after SV infection as de- 
scribed in the Materials and Methods. After 13-14 h of SV infection in N18 cells, morphologic evidence of apoptosis as monitored by 
phase contrast microscopy is observed. SE bars for glutathione levels are not shown but represent less than 5 % the mean value for each 
treatment group.  Open squares, control, no drug; closed triangles,  SV-infection, no drug; open circles, SV infection plus 20 ~M BSO; 
closed squares, SV infection plus 20 tzM BSO plus 50 mM N-acetyl-L-cysteine. Note that SV infection alone does not cause a decrease in 
total glutathione levels. Rather SV infection increases glutathione levels. (E) NAC protects from SV-induced apoptosis in N18 cells de- 
spite the depletion of glutathione induced by 20 ixM BSO suggesting that glutathione is not necessary for NAC protection. Error bars 
represent SEM (n =  3). Asterisk denotes p  <  0.05. 
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(or prevent a decrease in) intracellular glutathione. NAC 
has been shown to deliver cysteine, the rate-limiting amino 
acid precursor in glutathione synthesis, intracellularly (Meis- 
ter and Anderson,  1983;  Kudo and Kosower, 1990), and 
thus to increase glutathione levels (Issels et al., 1985). To 
test whether glutathione synthesis is  required" for NAC's 
prevention of SV-induced apoptosis, we used buthionine 
sulfoximine (BSO). BSO is an irreversible inhibitor of the 
enzyme ",t-glutamyl cysteine synthetase, and acts to inhibit 
cysteine (or cysteine derived from deacylated NAC) incor- 
poration into glutathione (Griffith and Meister, 1979). BSO 
(20 txM) lowered total cellular glutathione (GSSG +  GSH) 
to less than 20% of control levels by 3 h after infection (Fig. 
1 D), but did not cause cell death in uninfected cells nor 
did it affect SV's ability to induce apoptosis (Fig. 1 E). Ad- 
ditionally, when de novo glutathione synthesis was blocked 
with BSO, NAC still prevented SV-induced cell death (Fig. 
1 E). Thus, glutathione synthesis is not required for NAC 
protection. 
Metal Chelators and Inhibitors of Lipid 
Peroxidation Do Not Mimic NA C's Ability to Block 
SV-Induced Apoptosis 
An additional well documented action of NAC is its ability 
to act as a chelator of trace metals. The chelating proper- 
ties of NAC may be related to its resemblance to cysteine, 
which has a high affinity for copper, iron, and zinc. In high 
intravenous doses in vivo, NAC has been shown to have 
heavy metal-chelating effects (Lorber et al., 1973; Hjortso 
et al.,  1990).  By preventing several metal-catalyzed reac- 
tions that generate oxygen radicals, metal chelators can act 
as antioxidants. Indeed, iron chelators have been shown to 
inhibit oxidative stress and cell death in a number of para- 
digms (Sakaida et al.,  1989; Connor and Benkovic, 1992; 
Gille et al., 1992; Hartley et al., 1993). 
To test the possibility that these chelating properties of 
NAC are responsible for its protective actions, we exposed 
infected cells to the iron chelators, mimosine (MIM) and 
deferoxamine mesylate  (DFO).  DFO  (50-500  IxM)  and 
MIM  (50-300  ~M)  each failed to prevent SV (AR339)- 
induced apoptosis (Table I). At the highest concentrations 
utilized, control cells began to manifest toxic effects from 
the drugs. To ensure that the drugs were biologically ac- 
tive in our hands, we performed parallel experiments in 
which cortical neurons were subjected to glutathione de- 
pletion and oxidative stress. Treatment of cortical cultures 
with DFO  (50 txM)  or MIM (100 txM) completely inhib- 
ited oxidative stress-induced apoptosis (R. R. Ratan, un- 
published observations). 
In addition to DFO  and MIM,  the Fe/Cu/Zn chelator 
penicillamine also failed to prevent SV (AR339)-induced 
apoptosis. These results suggest that the protective effects 
of NAC do not relate solely to its ability to bind metals. 
Furthermore the absence of protection by metal chelators 
suggests that the metal-catalyzed formation of free radi- 
cals, in particular hydroxyl radical, is not likely to be an 
important  mediator  of SV-induced  apoptosis.  Addition- 
ally, we found that inhibitors of lipid peroxidation, buty- 
lated hydroxyanisole (BHA, 0.1 ixM-100 txM), and the vi- 
tamin E  analogue, Trolox (10 ixM-1 mM), did not inhibit 
Table I. Effects of  Antioxidants on SV-induced Apoptosis 
% Viability ±  SEM 
CON  SV 
Metal chelators 
Mimosine (0.05--0.5 mM)  77 -  2  17 -  2 
Deferoximine Nesyiate (0.1-0.5 mM)  69 +_ 6  17 _+ 4 
Penicillamine (0.1-1.0 mM)  93 _+  1  22-4-  12 
Inhibitors of Lipid Peroxidation 
BHA (0.01-0.5 mM)  98 ±  1  11  --- 7 
Trolox (0.1-1.0 mM)  94 _+  1  21  ~  1 
Scavengers of Peroxide 
Catalase (10-3,000 units/ml)  96 _+  1  5  _+  1 
Pyruvate (2-10 mM)  100 ±  1  12 ±  3 
Thiol Agents 
Pyrrolidine dithiocarbamate (20-75  p~M)  79 ±  4  76 -  3** 
Diethyl dithiocarbamate (0.05-10 mM)  80 ±  4  78 ~- 3** 
Dithiothreitol (0.1-10 mM)  65 --- 6  74 ~  2** 
2-Mercaptoethanol (0.15-15.0 mM)  81  _+ 2  83 ±  1"* 
Cells were infected with SV (MOI-1-5)  ± potential inhibitors and percent viability  as- 
sessed after 48 h as described in the Materials and Methods.  Values (mean ±  SEM for 
three to five different experiments) represent the highest concentration  used for each 
drug treatment.  Control viability  refers to percent viability in drug treated,  uninfected 
cells after 48 h. 
** Statistical difference from control,  infected cells. (p <  0.05). 
SV (AR339)-induced apoptosis (Table I) nor did enzymic 
(catalase,  10-3,000  units/ml)  or  nonenzymic scavengers 
(pyruvate, 2-10 mM) of peroxide. These observations do 
not exclude the possibility that other oxygen-derived spe- 
cies such as superoxide or nitric oxide are operative. It is 
also important to note that we cannot rule out the possibil- 
ity that NAC acts as metal chelator, peroxide scavenger, 
and/or an inhibitor of lipid peroxidation in a subcellular lo- 
cal unaffected by DFO, MIM, penicillamine, BHA, Trolox, 
catalase, or pyruvate. 
Thiol Agents Such As PDTC, 2-Mercaptoethanol and 
DTT Inhibit SV (AR339)-induced Apoptosis 
Since an isolated role for the glutathione enhancing (spar- 
ing) effects of NAC as well as its metal chelating proper- 
ties seemed unlikely, we  examined whether agents with 
only thiol reducing properties could mimic NAC's protec- 
tive action. 2-ME and other thiols have been demonstrated 
to increase viability and proliferation in both neuronal and 
nonneuronal cells (Grill and Pixley, 1993; Sandstrom et al., 
1993). The beneficial effects of 2-ME have been attributed 
to its ability to deliver cysteine intracellularly and/or act as 
a reducing agent and thereby inhibit oxidative stress or al- 
ter the redox state of protein sulfhydryls. 2-ME prevented 
SV-induced apoptosis in a  dose-dependent manner with 
maximal protection at 14 mM (Table I). Other thiol agents 
such as DTT (10 mM) were also protective (Table I), while 
the vicinal dithiol, PDTC, was much more potent, signifi- 
cantly  protecting  SV  (AR339)-infected  N18  neuroblas- 
toma cells or AT-3 prostate carcinoma cells at concentra- 
tions of 75 txM (Table I). Diethyl dithiocarbamate (DDTC), 
a  structural analogue of PDTC, was  also protective, but 
was less potent than PDTC. These findings suggest that it 
is  the  thiocarbamate  moiety that  is  critical  for PDTC's 
protective  action.  The  differences  in  potency  between 
PDTC and DDTC have been observed in other paradigms 
Lin et al. NF-kappa B Activation  and Alphavirus  1153 and  may relate  to  differences in  membrane permeability 
between the two agents (Schreck et al., 1992).  With both 
PDTC  and  DDTC,  we  noted  a  small  and  reproducible 
amount of cell death in uninfected cells (Table I). 
In summary, we found that several thiol containing agents, 
including NAC (30 mM) and PDTC (75 IxM) are effective 
suppressors of SV (AR339)-induced  apoptosis. These re- 
sults,  added  to observations from other laboratories that 
NAC delays apoptosis induced by depriving T  cell hybri- 
domas of growth factors (Hockenbery et al., 1993), prevents 
apoptosis induced by exposing sensitized T cells to myelin 
basic protein (Sandstrom et al., 1994), and prevents apop- 
tosis induced by depriving PC12 cells of serum (Ferrari et 
al.,  1995),  are consonant with a common biochemical tar- 
get for NAC (applied at millimolar concentrations) in di- 
verse apoptotic paradigms. That other antioxidants such as 
metal chelators, BHA, Trolox, catalase, and pyruvate (Ta- 
ble I) are ineffective in preventing apoptosis may suggest 
that  SV (AR339)-induced  apoptosis can be redox modu- 
lated but is not oxidant initiated. 
NAC and PDTC: Effective Inhibitors  of 
NF-kappa B Activation 
The ability of NAC and PDTC and other thiol agents to in- 
hibit  SV(AR339)-induced  apoptosis led  us to look for a 
known  molecular target  that  is  affected by these  drugs. 
We were intrigued to find that NAC (30 mM) and PDTC 
(75 txM) are among the most effective known inhibitors of 
the  nuclear  translocation  of the  transcription  factor NF- 
kappa B  (Schreck and Baeuerle, 1991).  The striking phar- 
macologic parallel between the ability of NAC and PDTC 
to inhibit SV (AR339)-induced apoptosis and the ability of 
these drugs at similar concentrations to inhibit NF-kappa 
B stimulation by diverse, often pro-apoptotic, stimuli, led us 
to examine whether SV (AR339) induces NF-kappa B  ac- 
tivation. 
Sindbis  Virus Induces NF-kappa B Activation 
To investigate whether SV (AR339) infection triggers NF- 
kappa B  activation, we performed EMSAs on nuclear ex- 
tracts from infected and uninfected cells using a 32p-labeled 
oligonucleotide with a consensus NF-kappa B binding site 
(Staal et al., 1993).  We chose the palindromic NF-kappa B 
sequence that lies upstream of the MHC Class I promoter 
(5'-GGGGATTCCCC-3'). This binding site has been shown 
to bind a wide variety of heterodimers and homodimers of 
the NF-kappa B/rel family (Baldwin and Sharp, 1987; Bae- 
uerle, 1991; Potter et al., 1993). 
SV (AR339) infection strongly increased NF-kappa B like 
DNA binding in mouse N18 neuroblastoma cells and rat 
AT-3 prostate carcinoma cells (Fig. 2). Kinetic studies with 
a multiplicity of infection of 1-5 PFU per cell revealed that 
induction was maximal by 1 h and decreased by 3 h in the 
N18 cell line  (Fig. 2 A). In the  AT-3 prostate carcinoma 
cell line,  activation of NF-kappa B  was observed by 2  h 
and continued to increase up to 6 h  after infection (Fig. 2 
B). In both cell lines, the NF-kappa B binding activity was 
inhibited  in  a  concentration-dependent  manner  by cold 
oligonucleotide with a similar NF-kappa B sequence (Fig. 
2, A  and C), but not oligos containing mutations in the NF- 
kappa B site (not shown). 
Identification  of NF-kappa B Subunits in Nuclear 
Extracts Following SV Infection 
To identify the NF-kappa B  subunits  detected by EMSA 
in  infected N18 and AT-3 cell lines, we utilized  subunit- 
specific antibodies  to p50, p65, c-rel, and  rel-B. In AT-3 
cells addition of individual, subunit-specific antibodies dur- 
ing in vitro DNA binding revealed that the slower migrat- 
ing, major complex included p50/p65  while the faster mi- 
grating, minor complex was p50/p50 (Fig. 3). In N18 cells 
the identity of the major complex was composed of a het- 
Figure 2.  SV induces NF-kappa B activation  in N18 neuroblastoma cells and AT-3 cells. (A) SV induces transient activation  of NF- 
kappa B in N18 neuroblastoma cells. EMSAs were performed with 4-8 I~g of nuclear extracts using a 32p-labeled oligonucleotide  with a 
consensus NF-kappa B sequence from the MHC Class I promoter. An unlabeled oligonucleotide  containing a distinct NF-kappa B bind- 
ing sequence  (see Materials and Methods) was used for competition studies. Arrow points to predominant complex induced by SV. Ar- 
rowhead points to nonspecific complex. Note similar amounts of nonspecific nuclear activity among different  treatment groups. (B) SV 
induces activation of NF-kappa B in AT-3 prostate carcinoma cells. EMSAs were performed as described  in A. Large arrow points to 
predominant complex induced  by SV, small arrow to minor complex. Arrowhead points to nonspecific complex. (C) SV-induced NF- 
kappa B activity in AT-3 cells can be competitively inhibited by excess unlabeled NF-kappa B oligonucleotide. 
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the  major  complex  induced 
by SV in AT-3 cells  as p50/ 
p65. COOH-terminal subunit 
specific  antibodies to p50 or 
p65 were added after the ad- 
dition  of  radiolabeled  NF- 
kappa B probe to the nuclear 
binding mixture as described 
in  the  Materials  and  Meth- 
ods. Note that the  p50 anti- 
body decreases the intensity 
of the  major complex (large 
arrow) and completely inhib- 
its the intensity of the minor 
complex (small arrow). The 
p65  antibody completely in- 
hibits  the  major  complex 
(large arrow) and has no effect on the minor complex (small ar- 
row). The  major  complex  is  thus  composed  of  p50/p65  het- 
erodimers and the minor complex p50/p50  homodimers. Addi- 
tion of purified peptide (Ag) confirms the specificity of antibodies. 
erodimer of rel-B/p50 while  a faster migrating, but minor 
band was composed of p50/p50 (not shown). Antibodies to 
p65, c-rel, c-fos, Jun, and Egr-1 had no effect on any of the 
induced complexes. 
NA  C and PDTC Block SV (AR339)-induced NF-kappa 
B Activation as well as SV (AR339)-induced Apoptosis 
Parallel  experiments  assessing  the  effects  of  NAC  and 
PDTC  on  NF-kappa  B  binding  were  performed  by pre- 
treating cells with PDTC and NAC 2 h before SV (AR339) 
infection as in the viability studies. As observed previously 
with other activators of NF-kappa B (Schreck et al., 1992), 
PDTC  and  NAC diminished  the  SV-induced increase  in 
NF-kappa B activity in N18 cells (Fig. 4 A) and AT-3 cells 
(Fig. 4  B; PDTC not shown). Antioxidants  such as BHA 
(100 txM; not shown) and DFO (500 ~M, Fig. 4 B), which 
did not suppress SV-induced apoptosis, did not inhibit SV- 
induced  NF-kappa  B  activation.  We  confirmed  previous 
studies  that  have  demonstrated  that  NAC  and  PDTC, 
•  when added in vitro with nuclear extracts, do not affect the 
DNA binding of NF-kappa B. Rather, these agents appear 
to act by inhibiting translocation of NF-kappa B to the nu- 
cleus (Schreck et al., 1991, 1992; Meyer et al., 1994). 
Bcl-2 0verexpression in AT-3 Cells Inhibits SV-induced 
Apoptosis and SV-induced NF-kappa B activation 
Bcl-2 has been postulated to act in an antioxidant pathway 
in preventing apoptosis (Hockenbery et al., 1993; Kane et 
al., 1993), but the nature of the signaling pathway affected 
by bcl-2  remains  unclear.  The  AT-3  prostate  carcinoma 
cells  used  in  this  study  overexpress  the  neomycin  resis- 
tance  gene  alone  (AT-3 Neo)  and  have  previously been 
demonstrated to undergo SV-induced apoptosis (Levine et 
al.,  1993).  However, AT-3 Neo cells  overexpressing Bcl-2 
(AT-3  Bcl-2)  do not  undergo  SV-induced  apoptosis,  de- 
spite their ability to produce progeny virus for many months 
(Levine et al., 1993). Bcl-2 is thus able to convert SV infec- 
tion from a lytic (apoptotic) to a persistent form. To deter- 
mine  whether  Bcl-2's  protective  effects,  like  NAC  and 
PDTC, are correlated with inhibition of NF-kappa B signal- 
ing, we  compared  SV-induced NF-kappa  B  activation  in 
AT-3 Neo and AT-3 Bcl-2 cells. As shown in Fig. 4 C, up to 
6 h after infection, SV-induced NF-kappa B activation was 
almost completely suppressed in the presence of high lev- 
Figure 4.  NAC, PDTC and Bcl-2, agents that block SV-induced apoptosis,  also inhibit SV-induced NF-kappa B activation.  The iron che- 
lator and antioxidant, deferoxamine mesylate (DFO, 500 uM) does not inhibit SV-induced apoptosis and does not inhibit SV-induced 
NF-kappa B activation. (A) Effects of NAC (30 mM) and PDTC (75 ~M) on SV-induced NF-kappa B activation in N18 cells. Cells were 
pretreated for 2 h with NAC or PDTC before infection and nuclear extracts were harvested 1 h after the end of infection. Large arrow 
points to major complex, p50/rel B, whereas small arrow points to minor complex p50/p50. (B) Effects of NAC (30 mM) and DFO (500 
txM) on SV-induced NF-kappa B activation in AT-3 cells. Drugs were added as in A and nuclear extracts were harvested 4 h after end of 
the 1-h infection period. Large arrow points to major complex p50/p65, whereas small arrow points to minor complex p50/p50. (C) Ef- 
fects of bcl-2 overexpression on SV-induced NF-kappa B activation in AT-3 cells. 4 and 6 h after SV infection, nuclear extracts were pre- 
pared from AT-3 Neo and AT-3 Bcl-2 cells. In parallel,  Western blots using a bcl-2 antibody confirmed that the AT-3 Bcl-2 levels have 
high levels of Bcl-2 protein whereas none is detectable in the AT-3 Neo cells (not shown). Additionally, AT-3 Bcl-2 but not AT-3 Neo 
cells are resistant to SV-induced apoptosis (not shown). (D) Effects of overexpression of Bcl-2 in AT-3 cells on nuclear NF-kappa B 
binding activity and nuclear AP-1 binding activity. Nuclear extracts were obtained from AT-3 Neo and AT-3 Bcl-2 cells as in C and EMSAs 
were performed using 4 Ixg of protein and radiolabeled NF-kappa B or AP-1 probe. Excess unlabeled wild-type and mutant AP-1 oligo- 
nucleotides were used to confirm that the AP-1 binding activity observed in AT-3 Neo and AT-3 Bcl-2 cells is specific (not shown). 
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from  AT-3  Neo  and  AT-3  Bcl-2  cells  revealed  similar 
amounts of NF-kappa B  activity (not shown),  suggesting 
the absence of nuclear NF-kappa B DNA binding activity 
in  AT-3  Bcl-2  cells  cannot  be  attributed  to  loss  of NF- 
kappa B  expression.  Additionally,  differences in  nuclear 
NF-kappa B  activity between SV-infected AT-3 Neo and 
AT-3 Bcl-2 cell lines could not be attributed to global dif- 
ferences in nuclear proteins, as levels of the transcription 
factor AP-1 were similar in these two groups (Fig. 4 D). In 
data not shown, we confirmed previous studies that have 
shown that the AT-3 Bcl-2 cell line expresses high levels of 
Bcl-2 protein and that these cells are resistant to SV-induced 
apoptosis (Levine et al., 1993). 
NF-kappa B Activation Is Necessary for SV 
(AR339)-induced  Apoptosis  in Rat AT-3 Prostate 
Carcinoma Cells, But Not in Mouse N18 
Neuroblastoma  Cells 
The ability of thiol agents and Bcl-2 to block NF-kappa B 
activation led us to determine whether NF-kappa B induc- 
tion  is  necessary  for  SV-induced  apoptosis.  To  inhibit 
SV-induced NF-kappa B  activation we employed double 
stranded  phosphorothioate  oligonucleotides  containing 
three NF-kappa B  binding sites.  Several previous studies 
have shown that these oligonucleotides, also known as tran- 
scription factor decoys (TFDs) are efficiently taken up by 
cells,  bind  activated NF-kappa B,  and  thus  prevent NF- 
kappa B  from binding to authentic target sites within the 
nucleus (Bielinska et al., 1990; Eck et al., 1993; Goldring et 
al., 1995).  TFDs with an NF-kappa B binding sequence or 
mutant TFDs (incapable of binding NF-kappa B with high 
affinity) were  added  to AT-3 cells  18-24 h  before infec- 
tion. Two distinct TFDs and their mutant pairs were uti- 
lized: (a) Kappa B-1 TFD, a  42-nucleotide oligomer with 
three NF-kappa B  binding sequences from the cytokine 1 
(CK-1) region of the GM-CSF promoter capable of bind- 
ing p65 homodimers or c-rel/p65  heterodimers  (Dunn et 
al., 1994), and (b) kappa B-2 TFD, a 42-nucleotide oligo- 
mer  with  three  consensus  sequences  capable  of binding 
NF-kappa  B  heterodimers  (e.g.,  pS0/p65  or  pS0/rel  B). 
After the  18-24-h pretreatment  period, the  medium was 
changed,  virus and TFDs were  added,  and then viability 
was measured 48 h later. 
Concentrations  of Kappa B-1  TFD  as  low as  500  nM 
showed nearly complete protection of AT-3 cells from SV 
(AR339)-induced  apoptosis as measured by LDH release 
(Fig. 5, A  and B), ethidium  homodimer staining (a dead 
cell stain)  (Fig.  6, A-C) and  DNA fragmentation (Fig. 6 
D).  The  protection was concentration  dependent  (Fig.  5 
A)  and  was  not  observed  with  500  nM  of  the  mutant 
Kappa B-1 TFD (Fig. 5 B). The ability of wild-type kappa 
B-1  TFD  but  not  the  mutant  kappa B-1  TFD  to  inhibit 
NF-kappa B  translocation was verified by measurements 
of nuclear NF-kappa B binding as assayed by EMSA (Fig. 
6 E). To confirm that inhibition of NF-kappa B binding to 
3zp-labeled oligonucleotide was not due to the presence of 
residual  cold  TFDs copurified  with  nuclear  extracts,  we 
performed a  mixing experiment.  If the  inhibition  of NF- 
kappa B binding seen in nuclear extracts from virus-infected, 
TFD-treated cells were  due  to residual  cold TFDs,  then 
Figure 5.  Inhibition of NF-kappa B  activation  using NF-kappa 
B-specific TFDs blocks SV-induced apoptosis in AT-3 cells. (A) 
Concentration response of protection by kB-1 WT TFDs 48 h af- 
ter SV infection in AT-3 cells. 125-500 nM WT kB-1 was added 
to AT-3 cells 18-24 h before infection,  The cells were infected 
and maintained after infection  in the presence of the TFD until 
the percent viability was measured by determining the percent 
LDH released into the medium as described in the Materials and 
Methods. The kB-1 TFD binds p65 homodimers or p65/c-rel het- 
erodimers.  Error bars represent SEM  (n  =  3).  (B) Effects  of 
wild-type TFDs and mutant TFDs on SV-induced apoptosis. The 
binding  specificity of kappa B-1  is described  in A.  Kappa B-2 
binds  p50/p65 and  other  NF-kappa  B  heterodimers.  Mutant 
TFDs (kappa B-1 or kappa B-2) did not alter viability in unin- 
fected cultures (not shown). Error bars represent SEM (n = 3). 
they should be able to inhibit the NF-kappa B binding ac- 
tivity  detected  in  nuclear  extracts  from  control,  virus- 
infected cells. We found that the intensity of NF-kappa B 
binding in extracts prepared from virus-infected, TFD un- 
treated cells was not diminished by incubation with virus- 
infected, TFD treated extract suggesting that cold TFD was 
not copurified with the  nuclear extract. We also verified 
that incubation of AT-3 cells with wild-type NF-kappa B 
TFDs does  not  alter  the  nuclear  activity of another re- 
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infected cells (data not shown). We also verified that wild- 
type and mutant NF-kappa B TFDs do not affect viral pro- 
duction at 4, 24, or 48 h after infection (data not shown). 
Kappa B-2 TFD (5 txM), but not the mutant kappa B-2 
TFD (5 I~M) was equally as effective as kappa B-1 in pre- 
venting  SV-induced  apoptosis  (Fig.  5  B).  The  ability  of 
two TFDs with distinct NF-kappa B binding site sequences 
to  inhibit  SV  (AR339)-induced  apoptosis  suggests  that 
NF-kappa B activation is necessary for SV (AR339)-induced 
apoptosis in AT-3 cells. 
Accumulating evidence suggests the existence  of multi- 
pie stimulus-specific and cell type-specific signaling paths to 
apoptosis. For example, while thymocyte apoptosis induced 
by radiation or etoposide is dependent on p53, thymocyte 
apoptosis  induced  by  glucocorticoids  or  calcium  is  p53- 
independent (Clarke et al., 1993). Additionally, recent ob- 
servations indicate that Bcl-2 overexpression prevents SV- 
induced apoptosis in AT-3 prostate carcinoma cells, while 
overexpression of Bcl-2 in BHK cells has no effect on SV- 
induced apoptosis (J. M. Hardwick, unpublished observa- 
tions). To determine whether kB TFDs prevent SV-induced 
apoptosis in a  cell type-specific manner, we examined the 
effects of these agents on N18 neuroblastoma cells. Treat- 
ment of mouse N18 neuroblastoma  cells with 500 nM-30 
ixM  kappa  B-1  TFD  or 500 nM-30  txM kappa  B-2 TFD 
had no effect on SV-induced apoptosis and did not affect 
cell survival in uninfected cultures  (Fig. 7 A). Despite its 
failure  to  inhibit  SV-induced  apoptosis,  the  kappa  B-2 
TFD  was  capable  of  nearly  completely  inhibiting  SV- 
induced nuclear NF-kappa B  activity as shown by EMSA 
(Fig. 7 B). These results suggest that while NF-kappa B ac- 
tivation  is  necessary  for  SV-induced  apoptosis  in  AT-3 
cells, it is not required for SV-induced apoptosis in N18 cells. 
Discussion 
An Alphavirus-Induced Apoptotic Pathway That 
Requires NF-kappa B Activation 
Using double stranded phosphorothioated  oligodeoxynu- 
cleotides as decoys to inhibit competitively binding of NF- 
Figure 6.  NF-kappa B TFDs block SV-induced increases in dead 
cell staining and DNA fragmentation characteristic of apoptosis. 
(A)  Uninfected  AT-3  cells  visualized  by Hoffman microscopy. 
(Aa) AT-3 cells depicted in A treated with Ethid-1.  (B) AT-3 cells, 
48 h after SV infection, visualized  by Hoffman microscopy. (Bb) 
AT-3 cells depicted in B treated with Ethid-1.  (C) AT-3 cells, 48 h 
after SV infection in the presence of 500 nM kappa B-1 WT oli- 
gonucleotide visualized  by Hoffman microsopy. (Cc) AT-3 cells 
depicted in C treated with Ethid-1. (D) Kappa B-1 WT TFD 500 
nM blocks SV-induced DNA fragmentation. DNA was harvested 
from 105 uninfected or infected cells 18 h after SV infection and 
subjected to agarose gel electrophoresis and ethidium  bromide 
staining.  In parallel,  4 x  105 cells treated with 500 nM kappa B-1 
WT TFD (wt oligo) were infected and the DNA was harvested. 
The bands from the standard 1-kb DNA ladder (GIBCO BRL) 
contain from 1 to 12 repeats of a 1,018-bp DNA fragment. In ad- 
dition to these 12 bands, the ladder contains vector DNA frag- 
ments that range from 75 to 1636 bp. (E) Kappa B-1 wt TFD (wt 
oligo) but not kappa B-1 mutant TFD (mutant oligo) block SV- 
induced nuclear NF-kappa B activity.  Wt or mutant TFDs (500 
nM) were added to AT-3 cells 18-24 h before infection and main- 
tained in the medium after infection as in Fig. 5 A. 4 h after infec- 
tion, nuclear extracts were obtained from cells  treated with no 
TFD, wt TFD  (500  nM)  and mutant TFD  (500  nM)  and  then 
EMSAs were performed. Bar, 25 ~m. 
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block SV-induced  apoptosis in N18 
cells. (A)  N18 neuroblastoma cells 
were  treated  with  30  p.M  WT  or 
mutant TFD (kappa B-1 and kappa 
B-2) as described  for AT-3 cells in 
Fig.  5.  Percent  viability  was  as- 
sessed  48  h  after infection  by the 
percent  of LDH released  into  the 
bathing medium.  Error bars repre- 
sent  SEM  (n  =  4). (B) Kappa B-2 
WT  TFD  (wt  oligo) blocks  SV- 
induced  NF-kappa B  activation  in 
N18 cells. 5 I~M kB-2 WT TFD was 
added to N18 cells 18-24 h before 
SV-infection.  Cells  were  infected 
and nuclear extracts were harvested 
one hour after the end of the infec- 
tion period. Large arrow points to the p50/relB complex and the 
small arrow points to the minor, p50/p50 complex.  The arrow- 
head points to nonspecific binding activity. 
kappa B to native DNA binding sites, we have shown that 
NF-kappa B  activation is necessary for SV-induced apop- 
tosis in AT-3 prostate carcinoma cells. Single-stranded an- 
tisense oligodeoxynucleotides designed to inhibit transla- 
tion of mRNAs have been shown to possess antiviral activity 
through nonspecific mechanisms including inhibition of vi- 
ral polymerase, inhibition  of viral absorption to  the  cell 
surface, and finally, disruption of proper intracellular vesi- 
cle trafficking essential for viral release into the cytoplasm 
(Milligan et al., 1993; Fennewald et al., 1995). Several obser- 
vations suggest that  the  double stranded  phosphorothio- 
ated  oligodeoxynucleotides  (TFDs)  used  in  the  present 
study are acting specifically to inhibit NF-kappa B  activa- 
tion. 
First, two wild-type NF-kappa B TFDs (kappa B-1 and 
kappa B-2) with  distinct  consensus  NF-kappa B  binding 
sequences, but not their corresponding mutant TFDs, block 
SV-induced  nuclear  NF-kappa B  activity (Fig.  6  E)  and 
SV-induced apoptosis (Figs. 5 and 6, A-D). The kappa B-1 
TFD binds p65/c-rel complexes and probably inhibits p50/ 
p65 nuclear translocation (Fig. 6 E) indirectly by binding 
p65 (Dunn et al., 1994) or by inhibiting the expression of 
p65 (R. Narayanan, unpublished observations). The kappa 
B-2 TFD  directly binds  p50/p65  and  other  NF-kappa B 
heterodimers  and  thereby competitively inhibits  the  nu- 
clear  translocation  of these  complexes  (Bielinska  et  al., 
1990; Eck et al., 1993). 
Second, the wild-type TFDs inhibit SV-induced nuclear 
NF-kappa B activity but not nuclear AP-1 activity. Recent 
studies have identified c-jun, a  member of the jun family 
and a subunit of the transcription factor AP-1, as a neces- 
sary component of growth factor deprivation-induced apop- 
tosis in sympathetic neurons (Estus et al., 1994; Ham et al., 
1995).  Our  observations exclude  the  possibility that  NF- 
kappa B TFDs are altering levels of AP-1 nuclear activity 
and  thereby  inhibiting  apoptosis.  Finally,  the  failure  of 
NF-kappa B  TFDs at concentrations  up to 30  I~M to in- 
hibit  SV-induced  apoptosis  in  N18  neuroblastoma  cells 
(Fig. 7 A) suggests that nonspecific effects of oligodeoxy- 
nucleotides  on viral adsorption,  viral replication  or viral 
entry are unlikely. Indeed, we found no effect of wild-type 
or mutant NF-kappa B TFDs on virus production at 4, 24, 
or 48 h after infection (data not shown). 
Our results suggest that identification of gene targets for 
NF-kappa B in AT-3 cells may shed light on regulators or 
effectors  of  SV-induced  apoptosis.  Several  genes  impli- 
cated in apoptosis such as p53 (Wu and Lozano, 1994), c-myc 
(Evan et al.,  1992), TGF-13  (Kyprianou and Isaacs, 1989; 
Perez et al.,  1994)  murine interleukin  1-13 converting en- 
zyme  (ICE)  (Casano  et  al.,  1994),  have  consensus  NF- 
kappa  B  sites  in  their  promoters.  Expression  of one  or 
more of these known proteins and/or as yet undefined pro- 
teins may thus be inhibited by NF-kappa B  TFDs. How- 
ever, our results do not allow us to establish whether gene(s) 
transactivated by NF-kappa B and required for SV-induced 
apoptosis are constitutively expressed or whether they are 
upregulated  in  response  to  viral  infection.  NF-kappa B 
TFDs were added to cells 18-24 h before infection allowing 
sufficient time not only for accumulation of TFDs intracel- 
lularly, but potentially, also for inhibition of constitutively 
expressed NF-kappa B-dependent genes before viral infec- 
tion. Available evidence suggests that effectors of apopto- 
sis are constitutively expressed in  a  variety of cell types, 
while  as  yet  undefined  regulators  may require  de  novo 
protein synthesis after the onset of an apoptotic stimulus 
(Jacobson et al., 1994).  Future studies will clarify whether 
NF-kappa B  regulates constitutively expressed and/or vi- 
rus-induced proteins necessary for apoptosis. 
Several independent observations suggest a role for NF- 
kappa B  in regulating apoptosis by other stimuli in addi- 
tion to SV. First, almost all activators of NF-kappa B, in- 
cluding TNF-et (Polunovsky et al.,  1994),  IL-1 13 (Ankar- 
crona  et  al.,  1994),  peroxide  (Hockenbery et  al.,  1993), 
endotoxin (Abello et al., 1994), and HIV-1 (Malorni et al., 
1993),  have been  shown to  induce  apoptosis in  cultured 
cell lines. Second, all members of the NF-kappa B  family 
share homology in a 300 NH2-terminal amino acid stretch 
called the rel domain. Recent studies have implicated one 
member of this family c-rel, in mediating programmed cell 
death  during  avian  development  (Abbadie  et  al.,  1993). 
The mRNA for this  transcription  factor is selectively in- 
creased in those cells undergoing programmed cell death 
in the developing chick embryo. Additional in vitro studies 
revealed that overexpression of c-rel in bone marrow cells 
triggers apoptosis, consistent with a  role for c-rel in  this 
process. Third, increased  expression of v-rel, a  truncated 
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ciated with resistance to apoptosis induced by radiation, 
calcium ionophores or growth factor withdrawal (Neiman 
et al., 1991).  It has been postulated that in this paradigm, 
v-rel acts as a dominant negative and blocks gene transac- 
tivation by c-rel. Finally, NF-kappa B nuclear activity is in- 
creased  in  lymphocytes  undergoing  dexamethasone  or 
heat shock-induced apoptosis (Sikora et al., 1993).  While 
these converging lines  of inquiry make  the  idea  of NF- 
kappa B  as a  general mediator of apoptosis compelling, 
the observation that NF-kappa B TFDs block SV-induced 
apoptosis in AT-3 cells but not N18 cells suggests the exist- 
ence of apoptotic signaling pathways that are NF-kappa B 
independent. These results also suggest that the same stim- 
ulus may initiate different apoptosis pathways in a cell type- 
specific manner. The stimulus and cell type specificity of 
NF-kappa B's role in apoptosis is further underscored by a 
recent study that  demonstrated  that p65  knockout mice 
undergo extensive programmed cell death in the liver dur- 
ing embryogenesis (Beg et al., 1995). 
Cell Type-specific Apoptotic Pathways 
In this study, several differences in the SV-induced NF- 
kappa B response between AT-3 and N18 cells may explain 
the apparent lack of dependence of SV-induced apoptosis 
in N18 cells on NF-kappa B. First, in N18 cells, NF-kappa 
B is activated by 1 h after infection and decreases to near 
basal levels by 3 h after infection (Fig. 2 A). In contrast, in 
AT-3 cells, NF-kappa B  activation persists and increases 
up to 6 h  after infection (Fig. 2 B). Thus, persistent NF- 
kappa B  activation by a stimulus may result in activation 
of an apoptotic program, whereas those cells where NF- 
kappa B  is transiently activated may use other transcrip- 
tional or posttranscriptional paths to apoptosis. Ghosh and 
coworkers have recently shown that NF-kappa B  activa- 
tion can be transient or persistent depending on whether 
the  stimulus  induces the  activation of Ikappa  B-e~ com- 
plexes (transient response) or the activation of Ikappa B-et 
and Ikappa B-13 complexes (persistent response) (Thomp- 
son et al.,  1995).  These observations predict that in N18 
cells, SV induces the activation of Ikappa B-et complexes, 
whereas in AT-3 cells, SV-induces Ikappa B-t~ and Ikappa 
B-J3 complexes. They also raise the intriguing possibility 
that Ikappa B-13 regulates NF-kappa B complexes that can 
activate the apoptotic program. 
Second, the SV-induced heterodimer in N18 cells is rel 
B/p50 (not shown), whereas the induced heterodimer in 
AT-3 cells is p50/p65 (Fig. 3). The recent characterization 
of phenotypic differences in mutant mice deficient in rel B 
or p50 provides support for the view that individual NF- 
kappa B/rel family members play distinctive roles that can- 
not be mimicked by other family members (Sha et al., 1995; 
Weih et al., 1995). Thus, the p50/p65 heterodimer induced 
by SV in AT-3 cells may transactivate genes that are not 
activated by rel B/p50 in N18 cells. Finally, it is possible 
that N18 cells possess compensatory and/or redundant path- 
ways that allow activation of the  apoptotic program de- 
spite inhibition of nuclear NF-kappa B activity. 
Mechanism of  Action of Thiol Agents and Bcl-2 
In addition to implicating NF-kappa B in SV infection and 
apoptosis, our results identify SV-induced death as another 
apoptotic paradigm where drugs with antioxidant capabil- 
ity  such  as  NAC  and  PDTC  are  protective.  NAC  and 
PDTC have also been shown to inhibit peroxide induced 
NF-kappa B activation (Schreck et al., 1992). These obser- 
vations have led to a model in which oxygen radicals, pos- 
sibly peroxides, are a common second messenger utilized 
by multiple stimuli to activate NF-kappa B  (Schreck and 
Baeuerle, 1991) and under some circumstances, to activate 
apoptosis (Buttke and Sandstrom, 1994).  Several observa- 
tions herein suggest that NAC and PDTC may not be act- 
ing to buffer increases in free radical production or augment 
antioxidant defenses during  SV infection: (a)  millimolar 
concentrations of NAC are required to prevent SV-induced 
NF-kappa  B  activation (Fig. 4, A  and  B)  and apoptosis 
(Fig. 1 A) in N18 and AT-3 cells compared to ~M concen- 
trations of NAC  required to inhibit  apoptosis  in  known 
paradigms of oxidative stress (Ratan et al.,  1994b;  Roth- 
stein et al., 1994), (b) the failure of well established inhibi- 
tors of oxidative stress such as metal chelators, inhibitors 
of lipid peroxidation, and peroxide scavengers to abrogate 
SV-induced apoptosis (Table I) or SV-induced NF-kappa 
B activation (Fig. 4 B), and (c) the absence of a decrease in 
total glutathione, a marker of oxidative stress (Rehncrona 
et al., 1980; Kuo et al.,  1993; Ratan et al.,  1994b), in SV- 
infected cells before morphologic evidence of cell death 
(Fig. 1 C). Indeed, the recent observation that apoptosis 
induced by growth factor deprivation can occur under con- 
ditions of hypoxia argues against oxygen radicals as com- 
mon mediators of apoptosis (Jacobson and Raft, 1995). 
If NAC, PDTC and other thiol agents are not inhibiting 
SV-induced  oxidative stress,  by what  other mechanisms 
could these agents exert their protective actions? Accumu- 
lating evidence suggests that antioxidants can alter protein 
function by modulating the redox state of critical cysteine 
residues  or  metals  bound  to  proteins  (Stamler,  1994). 
Among the proteins identified as targets for oxidants and 
antioxidants are protein kinases and protein phosphatases 
(Bauskin et al.,  1991; Fischer et al., 1991).  Indeed, PDTC 
has been demonstrated to inhibit phosphorylation of Ikappa 
B, an event considered critical for NF-kappa B  activation 
(Traenckner et al., 1994). Additionally, recent studies have 
shown that induction of NF-kappa B by a wide variety of 
stimuli including peroxide can be inhibited by tyrosine ki- 
nase  inhibitors  (Anderson  et  al.,  1994).  Furthermore, 
tyrosine kinase inhibitors have been shown to abrogate ap- 
optosis due to ionizing radiation (Ucklun et al., 1992). Iden 
tification of SV-induced signaling pathways necessary for 
NF-kappa B activation may thus identify putative molecu- 
lar targets for NAC and other thiol agents that are critical 
to the anti-apoptotic actions of these agents. 
In this study, we also demonstrate that Bcl-2 overexpres- 
sion almost completely suppresses SV-induced NF-kappa B 
activation up to 6 h after infection in AT-3 cells (Fig. 4, C 
and D). Bcl-2 is thus able to inhibit NF-kappa B activation 
as well as apoptosis induced by SV. These results are con- 
sistent with previous observations that suggest that bcl-2 
abrogates  NF-kappa  B  activation induced by some,  but 
not all cytotoxic stimuli (Albrecht et al.,  1994).  They are 
also consistent with a causal role of NF-kappa B  in SV- 
induced apoptosis in AT-3 cells. Future studies will define 
the basis for bcl-2 inhibition of NF-kappa B signaling and 
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this pluripotent inhibitor of apoptosis exerts its protective 
actions. 
Sindbis virus is one of a growing list of viruses capable of 
activating NF-kappa  B  and inducing apoptosis (Pahl and 
Baeuerle,  1995). We have used thiol agents such as NAC 
and  PDTC,  the  protooncogene  Bcl-2  and  NF-kappa  B 
transcription factor decoys to demonstrate that SV-induced 
NF-kappa B signaling is necessary for SV-induced apopto- 
sis in AT-3 prostate carcinoma cells. These results add ap- 
optosis to the extensive  list of cell functions that can be 
regulated by NF-kappa B  (Thanos and Maniatis, 1995). It 
will be important to determine whether this transcription 
factor  signaling  pathway  is  necessary  for  apoptosis  in- 
duced by other viruses and other, nonviral apoptotic stim- 
uli. However, even if NF-kappa B is not a general mediator 
of apoptotic cell death, the ability of pluripotent inhibitors 
of apoptosis such as thiol agents and bcl-2 to abrogate SV- 
induced NF-kappa B  signaling and SV-induced apoptosis 
suggest that SV is a good model system in which to investi- 
gate the mechanism of action of these agents. Such investi- 
gations may elucidate novel approaches to diseases such as 
AIDS  where  NF-kappa  B  and apoptosis  are  believed  to 
play a  pathogenic role  (Gougeon and Montagnier, 1993; 
Staal et al., 1993) as well as to neurological diseases such 
as Spinal Muscular Atrophy (SMA) where apoptosis has 
been implicated (Roy et al., 1995). 
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